Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for type i interferon
Most Correlated Studies
- Monocytes from systemic lupus erythematosus patients and healthy donors treated with IFNa2b
- STAT1-deficient U3A cells transfected with IRF7 and IKKe and treated with type I interferon
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Most Relevant Literature
- CNS disease associated with enhanced type I interferon signalling.
- Differential signaling by type-I and type-III interferons in mucosa.
- Type I interferon pathway genetic variants in severe COVID-19.
- Assessment of type I interferon response in routine practice in France in 2022.
- TRIM28 facilitates type I interferon activation by targeting TBK1.
Most Relevant Clinical Trials
- A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases
- Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Fai…
- A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult T…
- Type I Interferon Alfa-2a in Postmastectomy Breast Reconstruction
- Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I
